Apr 03, 2017 11:02 am UTC| Business
EWING, N.J., April 03, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that data from the 52-week pharmacokinetics and safety phase 3 study of subcutaneous testosterone enanthate delivered through the...
Apr 03, 2017 11:02 am UTC| Business
EWING, N.J., April 03, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that data from the 52-week pharmacokinetics and safety phase 3 study of subcutaneous testosterone enanthate delivered through the...
Apr 03, 2017 11:02 am UTC| Business
EWING, N.J., April 03, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that data from the 52-week pharmacokinetics and safety phase 3 study of subcutaneous testosterone enanthate delivered through the...
uniQure Announces Presentations at Upcoming April Conferences
Apr 03, 2017 11:02 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, April 03, 2017 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
uniQure Announces Presentations at Upcoming April Conferences
Apr 03, 2017 11:02 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, April 03, 2017 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
uniQure Announces Presentations at Upcoming April Conferences
Apr 03, 2017 11:02 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, April 03, 2017 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
Cytori Appoints Gregg Lapointe to Board of Directors
Apr 03, 2017 11:02 am UTC| Business
SAN DIEGO, April 03, 2017 -- Cytori Therapeutics, Inc.(Nasdaq:CYTX) (“Cytori” or the “Company”) today announced that Gregg Lapointe has joined the Company’s Board of Directors to serve as an independent director,...